Article
Deciphering the role of aberrant DNA methylation in NAFLD and NASH
1 Oct 2022
Abstract excerpt
The global incidence of nonalcoholic fatty liver disease (NAFLD) is mounting incessantly, and it is emerging as the most frequent cause of chronic and end stage liver disorders. It is the starting point for a range of conditions from simple steatosis to more progressive nonalcoholic steatohepatitis (NASH) and associated hepatocellular carcinoma (HCC). Dysregulation of insulin secretion and dyslipidemia due to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
